A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1994
11/01/1994	US5360915 Therapeutic compositions having low toxicity
11/01/1994	US5360821 Method of use of pantothenic acid to improve the athletic performance and sense of well being of a human being
11/01/1994	US5360820 Medical use for tachykinin antagonists
11/01/1994	US5360817 Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents
11/01/1994	US5360816 Orally administering 5-methoxy-psoralen to a patient and then exposing patient to ultraviolet radiation
11/01/1994	US5360812 Fused 1,2,5-oxadiazole-2-oxides and their use
11/01/1994	US5360811 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
11/01/1994	US5360809 Imidazole compounds and their use as calcium channel blockers
11/01/1994	US5360808 Arylcarbonylaminoalkyl-dihydro-oxo-pyridines, their production and their use
11/01/1994	US5360805 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
11/01/1994	US5360804 Multicomponent agent or kit for preparing the sulpho-conjugated form of pyridino, pyrimidino or triazino N-oxide compounds and method of use
11/01/1994	US5360803 Composition and method for treating cancer
11/01/1994	US5360801 Pharmacological stimulation of eye growth
11/01/1994	US5360799 Substituted thienyl- or pyrrolylcarboxyclic acid derivatives, their preparation and medicines containing them
11/01/1994	US5360798 Bactericides
11/01/1994	US5360797 Bisphosphonic acid derivatives useful as anti-arthritic agents
11/01/1994	US5360795 Treating cytomegalo virus and herpes simplex viruses
11/01/1994	US5360793 Foaming, xanthan gum, hexitol-stabilized aluminum hydroxide
11/01/1994	US5360792 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom
11/01/1994	US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells
11/01/1994	US5360734 Viricides for blood with photoactive materials, radiation a mixture with proteins
11/01/1994	US5360616 Solid, nonporous microspheres of an injectable steroid
11/01/1994	US5360613 Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol
11/01/1994	US5360612 Pharmaceutical compositions containing triazole derivatives for rectal administration
11/01/1994	US5360611 Antiinflammatory
11/01/1994	US5360610 Method for stimulating nerve fiber growth
11/01/1994	US5360605 Preservation of blood, tissues and biological fluids
11/01/1994	CA2070685C Method for treating painful, inflammatory or allergic disorders
11/01/1994	CA1332839C 8-substituted quinoline derivatives and their use in therapy
11/01/1994	CA1332838C 4-alkyl-1,4-dihydropyridines with paf-acether-antagonist activity
11/01/1994	CA1332837C 5- or 6-substituted .beta.-carboline-3-carboxylic acid esters
11/01/1994	CA1332836C 3-oxadiazole and 3-carboxylic acid .beta.-carboline derivatives, their production and their use as drugs
11/01/1994	CA1332835C Aliphatic carboxamides
11/01/1994	CA1332834C Substituted basic 2-aminotetralins
11/01/1994	CA1332812C Dental material for the control of caries and paradentitis
11/01/1994	CA1332811C Treatment of ocular hypertension with class i calcium channel blocking agents
11/01/1994	CA1332810C Veterinary composition against endoparasites and process for the preparation thereof
11/01/1994	CA1332809C Sustained release pharmaceutical compositions
10/1994
10/31/1994	CA2122290A1 Pyrrolopyrazinic compounds, methods for their preparation and pharmaceutical compositions containing them
10/30/1994	CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors
10/30/1994	CA2122193A1 Lifibrol and its use
10/29/1994	CA2121991A1 Butyrophenone transdermal compositions
10/28/1994	CA2122001A1 2,6-disubstituted 4-quinolyl-dihydropyridines
10/28/1994	CA2122000A1 2-amino-5-cyano-4- quinolyldihydropyridine esters, processes for their preparation and their use in medicaments
10/28/1994	CA2121999A1 Quinolyl-dihydropyridine esters, processes for their preparation, and their use in medicaments
10/28/1994	CA2121980A1 Condensed quinolyl-dihydropyridines, processes for their preparation and their use in medicaments
10/28/1994	CA2121971A1 3-quinolyl-substituted dihydropyridines, processes for their preparation and their use in medicaments
10/28/1994	CA2121963A1 2-amino-4-heteroaryl-1,4- dihydropyridines, processes for their preparation and their use in medicaments
10/28/1994	CA2121962A1 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
10/28/1994	CA2120054A1 Transdermal delivery of active drugs
10/27/1994	WO1994024298A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound
10/27/1994	WO1994024297A1 Defective recombinant adenoviruses for gene therapy of tumours
10/27/1994	WO1994024163A2 Bispecific antigen-binding molecules
10/27/1994	WO1994024149A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
10/27/1994	WO1994024146A1 Novel androgens and anabolic agents
10/27/1994	WO1994024145A1 Derivatives of triterpenoid acids and uses thereof
10/27/1994	WO1994024143A1 Method of forming oligonucleotides
10/27/1994	WO1994024134A1 New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use
10/27/1994	WO1994024133A1 Ring-substituted cell signaling inhibitors
10/27/1994	WO1994024132A1 Tetrahydro-pyrido-indole
10/27/1994	WO1994024131A1 Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders
10/27/1994	WO1994024130A1 New pyridinium salts and their use for controlling helicobacter bacteria
10/27/1994	WO1994024129A1 Phenylpyrrole derivatives and their use as antipsychotic agents
10/27/1994	WO1994024127A1 Indole derivatives as 5-h1-like agonists for use in migraine
10/27/1994	WO1994024125A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
10/27/1994	WO1994024121A1 Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
10/27/1994	WO1994024116A1 Heterocyclic derivatives in the treatment of ischaemia and related diseases
10/27/1994	WO1994024108A1 Michellamines useful as antiviral agents
10/27/1994	WO1994024107A1 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
10/27/1994	WO1994024094A1 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives
10/27/1994	WO1994024093A1 Ornithine decarboxylase inhibiting cyclic aminooxy compounds
10/27/1994	WO1994024084A1 Cyclopentene derivatives as endothelin receptor antagonists
10/27/1994	WO1994023767A1 Oral drug delivery compositions and methods
10/27/1994	WO1994023756A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	WO1994023754A1 Use of neuro-derived fetal cell lines for transplantation therapy
10/27/1994	WO1994023753A1 Cancer therapy, using antibody conjugates, in combination with a vasoactive agent
10/27/1994	WO1994023738A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
10/27/1994	WO1994023726A1 Calmodulin blocking agent adducts useful as anti-platelet agents
10/27/1994	WO1994023725A1 Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
10/27/1994	WO1994023724A1 Membrane-permeant second messengers
10/27/1994	WO1994023723A1 Adenosine receptor agonists for the promotion of wound healing
10/27/1994	WO1994023722A1 Hydrocortisone buffering activity
10/27/1994	WO1994023721A1 Novel medicinal use of dihydropyridine derivative
10/27/1994	WO1994023720A1 Tetrahydro-beta-carbolines
10/27/1994	WO1994023719A1 Ophthalmic use of muscarinic agonists having increased duration of activity
10/27/1994	WO1994023718A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
10/27/1994	WO1994023717A1 Methods of using hesperetin for sebum control and treatment of acne
10/27/1994	WO1994023716A1 Method for treatment of menopausal and premenstrual symptoms
10/27/1994	WO1994023715A1 Use of flavonoids to treat multidrug resistant cancer cells
10/27/1994	WO1994023713A1 Transdermal antiinflammatory composition
10/27/1994	WO1994023712A1 Ionene polymers as anthelmintics in animals
10/27/1994	WO1994023711A1 Stable ketamine solutions
10/27/1994	WO1994023708A1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses
10/27/1994	WO1994023707A1 Active substance-containing plaster
10/27/1994	WO1994023691A2 Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt
10/27/1994	WO1994023688A2 Cosmetic and medicinal topical preparations
10/27/1994	WO1994023638A2 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome
10/27/1994	WO1994020102A3 Medicament for treating or preventing cerebrovascular diseases
10/27/1994	WO1994019343A3 Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
10/27/1994	DE4313428A1 Combination patent comprising alpha -lipoic acid + pantothenic acid (or dexpanthenol) against inflammations, skin diseases of inflammatory + allergic nature, poorly healing wounds

1 ... 7070 7071 7072 7073 7074 7075 7076 7077 7078 7079 7080 7081 7082 7083 7084 7085 7086 7087 7088 7089 7090 ... 7860